Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasmodium vivax malaria vaccine development.

M Arévalo-Herrera1, S Herrera

  • 1Immunology Institute, Universidad del Valle, Cali, Colombia. marami@inmuno.univalle.edu.co

Molecular Immunology
|December 14, 2001
PubMed
Summary

Developing a Plasmodium vivax malaria vaccine is crucial due to its widespread impact. Research focuses on CS protein, asexual blood stage candidates (MSP-1, DBP), and transmission-blocking antigens (Pvs25, Pvs28).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcomes of Intra-Abdominal Candidiasis by Initial Antifungal Therapy.

Mycoses·2026
Same author

Chromosome-level genome assembly of the Vermilion Snapper (Rhomboplites aurorubens).

Scientific data·2025
Same author

Gel nail polish does not have a negative impact on the nail bacterial burden nor on the quality of hand hygiene with an alcohol-based hand rub.

The Journal of hospital infection·2024
Same author

Eosinophilic ascites: An unusual presentation of postgestational eosinophilic gastroenteritis.

Revista de gastroenterologia de Mexico (English)·2024
Same author

Carriage of multidrug-resistant Gram-negative bacilli: duration and risk factors.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2023
Same author

Analysis of the effectiveness and safety of short-stay units in the hospitalization of patients with acute heart failure. Propensity Score SSU-EAHFE.

Revista clinica espanola·2022

Area of Science:

  • Malariology
  • Vaccinology
  • Immunology

Background:

  • Plasmodium vivax is the most common malaria parasite globally, causing significant morbidity and economic burden.
  • Its relapsing nature and emerging drug resistance complicate malaria control efforts.
  • Developing a P. vivax-specific vaccine is challenging due to biological differences from P. falciparum and limited understanding of immune responses.

Purpose of the Study:

  • To characterize the P. vivax Circumsporozoite (CS) protein antigenically and assess its immunogenicity.
  • To evaluate the immunogenicity and protective efficacy of asexual blood stage vaccine candidates, including merozoite surface protein 1 (MSP-1) and Duffy-binding protein (DBP).
  • To assess the immunogenicity of ookinete surface proteins (Pvs25, Pvs28) and their transmission-blocking efficacy.

Main Methods:

  • Antigenic characterization of P. vivax CS protein.
  • Immunogenicity and protective efficacy studies in the Aotus monkey model for asexual blood stage candidates.
  • Assessment of transmission-blocking efficacy using Anopheles albimanus mosquitoes for ookinete surface proteins.

Main Results:

  • The study describes the current status of various P. vivax vaccine candidates.
  • Immunogenicity of P. vivax CS protein was tested in the Aotus monkey model.
  • Efficacy of asexual blood stage and transmission-blocking vaccine candidates is under evaluation.

Conclusions:

  • Significant progress is being made in developing P. vivax-specific vaccine candidates.
  • Multiple antigens targeting different parasite stages are being investigated.
  • Further research is essential to combat the challenges posed by P. vivax malaria.

Related Experiment Videos